Search research articles
Contact Us
Filters
Showing results (371-380 of 400) with videos related to
Page
of 40
Sort By:
The Pharmacogenomics Journal
|
June 6, 2007
Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy
A Ruzzo, F Graziano, F Loupakis, et al.
The Pharmacogenomics Journal
|
December 6, 2017
MTHFR, TS and XRCC1 genetic variants may affect survival in patients with myelodysplastic syndromes treated with supportive care or azacitidine
G Visani, F Loscocco, A Ruzzo, et al.
AIDS Research and Human Retroviruses
|
August 20, 2025
The Immunogenicity of AAV-Encoded HIV-1 bNAbs in Rhesus Macaques Is Unaffected by a Short Course of the Immunomodulator CTLA4Ig
Patricia A Hahn, Siddhartha Shandilya, Lucas A B da Costa, et al.
Plos Pathogens
|
October 1, 2019
Vaccine protection against rectal acquisition of SIVmac239 in rhesus macaques
Lucas Gonzalez-Nieto, Isabelle M Castro, Georg F Bischof, et al.
Frontiers in Immunology
|
July 15, 2022
Plasmablast Expansion Following the Tetravalent, Live-Attenuated Dengue Vaccine Butantan-DV in DENV-Naïve and DENV-Exposed Individuals in a Brazilian Cohort
Cássia G T Silveira, Diogo M Magnani, Priscilla R Costa, et al.
Journal of Virology
|
December 14, 2018
The Frequency of Vaccine-Induced T-Cell Responses Does Not Predict the Rate of Acquisition after Repeated Intrarectal SIVmac239 Challenges in <i>Mamu-B*08<sup>+</sup></i> Rhesus Macaques
Mauricio A Martins, Lucas Gonzalez-Nieto, Young C Shin, et al.
Nature
|
July 31, 2025
Determinants of successful AAV-vectored delivery of HIV-1 bNAbs in early life
Amir Ardeshir, Daniel O'Hagan, Isha Mehta, et al.
Reviews on Recent Clinical Trials
|
December 24, 2009
Parallel conduction of the phase I preventive and therapeutic trials based on the Tat vaccine candidate
S Bellino, V Francavilla, O Longo, et al.
British Journal of Cancer
|
October 25, 2017
Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients
A Ruzzo, F Graziano, Fabio Galli, et al.
Journal of Virology
|
August 21, 2015
Vaccine-Induced Simian Immunodeficiency Virus-Specific CD8+ T-Cell Responses Focused on a Single Nef Epitope Select for Escape Variants Shortly after Infection
Mauricio A Martins, Damien C Tully, Michael A Cruz, et al.
Page
of 40
Search research articles
Search
Showing results (371-380 of 400) with videos related to
Sort By:
Page
of 40
The Pharmacogenomics Journal
|
June 6, 2007
Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy
A Ruzzo, F Graziano, F Loupakis, et al.
The Pharmacogenomics Journal
|
December 6, 2017
MTHFR, TS and XRCC1 genetic variants may affect survival in patients with myelodysplastic syndromes treated with supportive care or azacitidine
G Visani, F Loscocco, A Ruzzo, et al.
AIDS Research and Human Retroviruses
|
August 20, 2025
The Immunogenicity of AAV-Encoded HIV-1 bNAbs in Rhesus Macaques Is Unaffected by a Short Course of the Immunomodulator CTLA4Ig
Patricia A Hahn, Siddhartha Shandilya, Lucas A B da Costa, et al.
Plos Pathogens
|
October 1, 2019
Vaccine protection against rectal acquisition of SIVmac239 in rhesus macaques
Lucas Gonzalez-Nieto, Isabelle M Castro, Georg F Bischof, et al.
Frontiers in Immunology
|
July 15, 2022
Plasmablast Expansion Following the Tetravalent, Live-Attenuated Dengue Vaccine Butantan-DV in DENV-Naïve and DENV-Exposed Individuals in a Brazilian Cohort
Cássia G T Silveira, Diogo M Magnani, Priscilla R Costa, et al.
Journal of Virology
|
December 14, 2018
The Frequency of Vaccine-Induced T-Cell Responses Does Not Predict the Rate of Acquisition after Repeated Intrarectal SIVmac239 Challenges in <i>Mamu-B*08<sup>+</sup></i> Rhesus Macaques
Mauricio A Martins, Lucas Gonzalez-Nieto, Young C Shin, et al.
Nature
|
July 31, 2025
Determinants of successful AAV-vectored delivery of HIV-1 bNAbs in early life
Amir Ardeshir, Daniel O'Hagan, Isha Mehta, et al.
Reviews on Recent Clinical Trials
|
December 24, 2009
Parallel conduction of the phase I preventive and therapeutic trials based on the Tat vaccine candidate
S Bellino, V Francavilla, O Longo, et al.
British Journal of Cancer
|
October 25, 2017
Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients
A Ruzzo, F Graziano, Fabio Galli, et al.
Journal of Virology
|
August 21, 2015
Vaccine-Induced Simian Immunodeficiency Virus-Specific CD8+ T-Cell Responses Focused on a Single Nef Epitope Select for Escape Variants Shortly after Infection
Mauricio A Martins, Damien C Tully, Michael A Cruz, et al.
Page
of 40